हिंदी में पढ़ें

Pharmaceuticals

Jubilant Cadista recalls 12,960 bottles of erosive esophagitis tablets

Jubilant Cadista recalls 12,960 bottles of erosive esophagitis tablets

Sun, Apr 14, 2019

Jubilant Cadista Pharmaceuticals Inc is recalling 12,960 bottles of the tablets in the strength of 40 mg, manufactured by Jubilant Generics Ltd at its Roorkee plant, the Enforcement Report of the US Food and Drug Adminstration (USFDA) said.

Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

Fri, Oct 19, 2018

Jubilant Cadista Pharmaceuticals Inc, is recalling over 1.58 lakh bottles of Pantoprazole Sodium delayed-release tablets manufactured by Jubilant Generics Ltd at its Roorkee plant, from the America and Puerto Rico market, latest report of the US health regulator has said.

Revenue growth to hit 5-year high in Q3: CRISIL Research

Revenue growth to hit 5-year high in Q3: CRISIL Research

Wed, Jan 10, 2018

Key highlights:

TRENDING NOW

Govt allows 100% FDI under automatic route for single brand retail

Wed, Jan 10, 2018

Union Cabinet today approved 100 per cent Foreign Direct Investment (FDI) under automatic route for single brand retail trading. Upto 49 per cent FDI is allowed under automatic route presently, but any investment beyond the limit requires government approval.

Biocon arm widens partnership terms with Bristol-Myers Squibb

Biocon arm widens partnership terms with Bristol-Myers Squibb

Tue, Nov 14, 2017

Biocon's contract research arm Syngene International has expanded its ongoing drug discovery and development with US-based Bristol-Myers Squibb till 2026.

Panacea Biotec signs seven drugs deal with Bionpharma Inc

Panacea Biotec signs seven drugs deal with Bionpharma Inc

Fri, Jul 28, 2017

Key Highlights 7 drugs represent a total estimated market potential of more than $800 million

Investor in Martin Shkreli's fund says he made millions

Investor in Martin Shkreli's fund says he made millions

Thu, Jul 06, 2017

One of the investors former drug company executive Martin Shkreli is accused of defrauding testified on Wednesday that Shkreli lied to him repeatedly, although he eventually made millions of dollars from the investment.

A final check: How GST impacts your toothpaste to your car purchase

A final check: How GST impacts your toothpaste to your car purchase

Fri, Jun 30, 2017

With the GST rollout at the stroke of midnight tonight here is how it will impact your business, industry and even your household finances.

Sun Pharma shares touch new lows as pricing pressure in US continues

Sun Pharma shares touch new lows as pricing pressure in US continues

Mon, May 29, 2017

Sun Pharma's fourth quarter results have been disappointing. The company said that pricing pressure in its US generic operation will continue for more time. Analysts, in the meantime, have begun downgrading the stock.

Dr Reddy's Q4 net profit rises by 319%

Dr Reddy's Q4 net profit rises by 319%

Fri, May 12, 2017

GV Prasad, Co-Chairman and CEO of Dr Reddy's Laboratories said, “FY17 has been challenging year due to lack of new product approvals for the US market. However, our other geoghraphies delivered good performance with several new product launches.”

56% disapprove of Republican health care bill: Poll

56% disapprove of Republican health care bill: Poll

Fri, Mar 24, 2017

"Replacing Obamacare will come with a price for elected representatives who vote to scrap it, say many Americans, who clearly feel their health is in peril under the Republican alternative," CNN quoted Tim Malloy, assistant director of the poll, as saying.

Glenmark receives tentative approval Fingolimod Capsules; shares down

Glenmark receives tentative approval Fingolimod Capsules; shares down

Mon, Mar 20, 2017

Glenmark’s current portfolio consists of 112 products authorized for distribution in the US marketplace.

Sun Pharma shares rise as USFDA clears Mohali facility

Sun Pharma shares rise as USFDA clears Mohali facility

Tue, Mar 14, 2017

Sun Pharma said, “It's subsidiaries or associate was informed by the US FDA yesterday, that it will lift the import alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the official action initiated (OAI) status."

Lupin launches pain relief drug in US; shares rise

Lupin launches pain relief drug in US; shares rise

Thu, Mar 09, 2017

Drug firm Lupin today announced the launch of pain relief drug Hydrocodone Bitartrate and Acetaminophen in the US market.

Wockhardt shares tank over 5% after US drug regulator warning

Wockhardt shares tank over 5% after US drug regulator warning

Thu, Mar 02, 2017

In a BSE filing on Wednesday, Wockhardt said, "The US Food and Drugs Administration (USFDA) has issued a warning letter to Morton Grove Pharmaceuticals, USA, a stepdown subsidiary of the company."

Aurobindo Pharma eyes US plant amid Trump push on jobs

Aurobindo Pharma eyes US plant amid Trump push on jobs

Fri, Feb 10, 2017

India`s drug industry is worth about $15 billion and supplies roughly 30 percent of the medicines sold in the United States.

Natco Pharma drops as USFDA makes six observations

Natco Pharma drops as USFDA makes six observations

Wed, Jan 25, 2017

Shares of Natco Pharma dropped 0.22% on NSE Nifty after the company said that USFDA conducted an inspection at its pharmaceutical factory in Kothur, near Hyderabad between January 16-24, 2017.

Everstone group acquires stake in OmniActive Health for $35 million

Everstone group acquires stake in OmniActive Health for $35 million

Mon, Jan 02, 2017

The deal is Everstone’s third in the healthcare and wellness sector in less than a year.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x